CMTM1_v17 is associated with chemotherapy resistance and poor prognosis in non-small cell lung cancer

Table 8 Multivariable analysis of OS and DFS in patients received NAC (n = 78)

Variable	OS			DFS
Variable	HR	95%CI	P value	HR	95%CI	P value
CMTM1_v17
High vs low	3.642	1.594–8.324	0.002	3.094	1.507–6.350	0.002
Pathological stage
III vs I/II	2.862	1.316–6.224	0.008	2.704	1.315–5.560	0.007
Gender
Male vs female				1.026	0.399–2.636	0.958
Histology
Adenocarcinoma vs non-Adenocarcinoma				2.038	0.879–4.727	0.097

P value was calculated using a two-sided log-rank test
OS overall survival, DFS disease-free survival, HR hazard ratio (log-rank), CI confidence interval.
Bold values are significant (P < 0.05)

ISSN: 1477-7819